Wells Fargo’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
Other funds holding PYXS
Wells Fargo's PYXS Position: Q3 2026 in Review
Wells Fargo increased its Pyxis Oncology (PYXS) stake by 392,027% in Q3 2026, buying an estimated $3.38M and bringing the position to 1,117,563 shares worth $2.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3141.
Wells Fargo first reported a position in PYXS in Q4 2021 and has held it in 20 quarters since. 101 funds tracked by Wall St. Rank hold PYXS as of Q3 2026.
- Wells Fargo held 1,117,563 shares of Pyxis Oncology worth $2.6M as of Q3 2026.
- Wells Fargo bought 1,117,278 Pyxis Oncology shares in Q3 2026, an estimated $3.38M.
- Pyxis Oncology made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #3141 holding.
- Wells Fargo first reported a position in Pyxis Oncology in Q4 2021 and has held it in 20 quarters since.
- 101 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2026.
Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.